Study Summary
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of CAR T cells immunotherapy in patients who have GD2, PSMA, Muc1, Mesothelin or other markers positive cervical cancer. Another goal of the study is to learn more about the persistence and function of CAR T cells in the body.
Want to learn more about this trial?
Request More InfoInterventions
Cervical cancer-specific CAR-T cellsBIOLOGICAL
1 infusion, for 1x10\^6\~1x10\^7 cells/kg via IV
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Shenzhen Geno-immune Medical Institute | Shenzhen | Guangdong | China |